Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
668
datasets available to search
ShareScore release 0.9.0
Dataset results
668 results for “Everolimus”
Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT00276575. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer
ClinicalTrials.gov study NCT01462214. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
ClinicalTrials.gov study NCT01583608. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01334502. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00255788. IPD Sharing: NO. Countries: 1. Publications: 1.
Everolimus Stent in Patients With Coronary Artery Disease (CAD)
ClinicalTrials.gov study NCT01182649. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China
ClinicalTrials.gov study NCT02842749. IPD Sharing: YES. Countries: 1. Publications: 0.
Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer
ClinicalTrials.gov study NCT01582191. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients with an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment
ClinicalTrials.gov study NCT05255133. IPD Sharing: NO. Countries: 1. Publications: 1.
Randomized Crossover of SVG101(Dispersible Tab. of Everolimus) and Afinitor 5mg in Healthy Adults
ClinicalTrials.gov study NCT05490095. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET
ClinicalTrials.gov study NCT01567488. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients
ClinicalTrials.gov study NCT02152943. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization
ClinicalTrials.gov study NCT01157455. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer
ClinicalTrials.gov study NCT01005199. IPD Sharing: NO. Countries: 3. Publications: 1.
SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System
ClinicalTrials.gov study NCT00180310. IPD Sharing: Not stated. Countries: 13. Publications: 12.
Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor.
ClinicalTrials.gov study NCT02732119. IPD Sharing: YES. Countries: 1. Publications: 0.
Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus
ClinicalTrials.gov study NCT02338609. IPD Sharing: YES. Countries: 3. Publications: 0.
A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma
ClinicalTrials.gov study NCT01412515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Optical Coherence Tomography for EVERolimus Eluting STent
ClinicalTrials.gov study NCT01146080. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer
ClinicalTrials.gov study NCT00567554. IPD Sharing: Not stated. Countries: 1. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.